Skye Bioscience, Inc.·4

Nov 6, 8:32 PM ET

Ward Keith Wayne 4

4 · Skye Bioscience, Inc. · Filed Nov 6, 2023

Insider Transaction Report

Form 4
Period: 2023-11-06
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2023-11-06+14,11020,001 total
    Exercise: $3.50Exp: 2033-08-25Common Stock (14,110 underlying)
Footnotes (1)
  • [F1]The option grant shall be exercisable for a price of $3.50 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023.
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact|2023-11-06

Documents

1 file
  • 4
    wk-form4_1699320737.xmlPrimary

    FORM 4